← Leaderboards
Markus Grompe
Oregon Health And Science University
$34,224,681
Attributed
$45,782,573
Total exposure
21
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.6M · FY2005–23$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$65,602,056 · 22
By mechanism
P01$29,959,679 · 8
R01$18,471,655 · 6
U01$12,078,693 · 3
UC4$3,604,708 · 1
RC1$998,778 · 1
R21$302,000 · 1
Top collaborators
- Mark A Kay11 shared
- Klaus H. Kaestner6 shared
- Philip R Streeter6 shared
- Hiroyuki Nakai5 shared
- Ben Z Stanger5 shared
- David W Russell3 shared
- Stephen A Duncan2 shared
- Willscott E Naugler2 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsIn VivoGene TherapyLiverHepatocyteStem CellsTransplantationSmall MoleculeGenesFundingFunctional DisorderBaseGeneticAdultFanconi&AposS AnemiaIn VitroDesignHepaticAnimal ModelHematopoietic Stem CellsPropertyProgramsLead
Grant awards (124)
In vivo selection of gene modified hepatocytes$495,054
R01 · FY2023 · DK · contact PI
Gene Therapy for Diabetes$699,431
U01 · FY2022 · DK
In vivo selection of gene modified hepatocytes$495,054
R01 · FY2022 · DK · contact PI
Gene Therapy for Diabetes$720,877
U01 · FY2021 · DK
In vivo selection of gene modified hepatocytes$495,054
R01 · FY2021 · DK · contact PI
Pathophysiology and Treatment of Fanconi Anemia$1,973,219
P01 · FY2020 · HL · contact PI
Gene Therapy for Diabetes$729,093
U01 · FY2020 · DK
Mechanisms of bile duct reprogramming$507,802
R01 · FY2020 · DK
Preclinical evaluation of small molecules with proven benefit in FA animal models$503,402
P01 · FY2020 · HL · contact PI
Administrative Core$40,591
P01 · FY2020 · HL · contact PI
Pathophysiology and Treatment of Fanconi Anemia$1,979,462
P01 · FY2019 · HL · contact PI
Gene Therapy for Diabetes$743,871
U01 · FY2019 · DK
Liver Cancer Risk with rAAV Gene Therapy$590,097
R01 · FY2019 · CA · contact PI
Mechanisms of bile duct reprogramming$507,802
R01 · FY2019 · DK
Preclinical evaluation of small molecules with proven benefit in FA animal models$503,528
P01 · FY2019 · HL · contact PI
Administrative Core$40,601
P01 · FY2019 · HL · contact PI
Pathophysiology and Treatment of Fanconi Anemia$1,985,543
P01 · FY2018 · HL · contact PI
Liver Cancer Risk with rAAV Gene Therapy$586,035
R01 · FY2018 · CA · contact PI
Mechanisms of bile duct reprogramming$507,802
R01 · FY2018 · DK
Preclinical evaluation of small molecules with proven benefit in FA animal models$503,652
P01 · FY2018 · HL · contact PI
Administrative Core$40,610
P01 · FY2018 · HL · contact PI
Pathophysiology and Treatment of Fanconi Anemia$1,804,077
P01 · FY2017 · HL · contact PI
Liver Cancer Risk with rAAV Gene Therapy$585,925
R01 · FY2017 · CA · contact PI
Mechanisms of bile duct reprogramming$507,802
R01 · FY2017 · DK
Transgene Persistence in Liver Gene Therapy$368,829
R01 · FY2017 · DK · contact PI
Preclinical evaluation of small molecules with proven benefit in FA animal models$314,620
P01 · FY2017 · HL · contact PI
Administrative Core$40,745
P01 · FY2017 · HL · contact PI
Pathophysiology and Treatment of Fanconi Anemia$1,875,381
P01 · FY2016 · HL · contact PI
Liver Cancer Risk with rAAV Gene Therapy$636,568
R01 · FY2016 · CA · contact PI
Mechanisms of bile duct reprogramming$522,802
R01 · FY2016 · DK
Transgene Persistence in Liver Gene Therapy$368,829
R01 · FY2016 · DK · contact PI
Preclinical evaluation of small molecules with proven benefit in FA animal models$323,785
P01 · FY2016 · HL · contact PI
Administrative Core$41,932
P01 · FY2016 · HL · contact PI
Liver Cancer Risk with rAAV Gene Therapy$608,126
R01 · FY2015 · CA · contact PI
Transplantation Assay for Liver Repopulating Cells$388,280
R01 · FY2015 · DK · contact PI
Transgene Persistence in Liver Gene Therapy$369,057
R01 · FY2015 · DK · contact PI
In vivo targeting of diabetes-relevant human cell types with rAAV vectors$3,604,708
UC4 · FY2014 · DK · contact PI
Pathophysiology and Treatment of Fanconi's Anemia$1,951,711
P01 · FY2014 · HL · contact PI
Transgene Persistence in Liver Gene Therapy$397,238
R01 · FY2014 · DK · contact PI
Transplantation Assay for Liver Repopulating Cells$388,280
R01 · FY2014 · DK · contact PI
Novel Sources of Transplantable Beta-cell Replacements$287,435
U01 · FY2014 · DK · contact PI
preclinical Testing of Novel Therapies in FA$278,816
P01 · FY2014 · HL · contact PI
Administrative Core$278,813
P01 · FY2014 · HL · contact PI
Cell Repository$278,813
P01 · FY2014 · HL · contact PI
Novel Sources of Transplantable Beta-cell Replacements$99,998
U01 · FY2014 · DK · contact PI
Pathophysiology and Treatment of Fanconi's Anemia$1,944,635
P01 · FY2013 · HL · contact PI
Novel Sources of Transplantable Beta-cell Replacements$1,326,946
U01 · FY2013 · DK · contact PI
Transplantation Assay for Liver Repopulating Cells$387,719
R01 · FY2013 · DK · contact PI
preclinical Testing of Novel Therapies in FA$262,631
P01 · FY2013 · HL · contact PI
Cell Repository$262,630
P01 · FY2013 · HL · contact PI
Administrative Core$262,629
P01 · FY2013 · HL · contact PI
Pathophysiology and Treatment of Fanconi's Anemia$2,077,422
P01 · FY2012 · HL · contact PI
Novel Sources of Transplantable Beta-cell Replacements$1,375,235
U01 · FY2012 · DK · contact PI
Transplantation Assay for Liver Repopulating Cells$344,780
R01 · FY2012 · DK · contact PI
Treatment of Distal Tyrosine Pathway Disorders$327,348
R01 · FY2012 · DK · contact PI
Administrative Core$297,329
P01 · FY2012 · HL · contact PI
preclinical Testing of Novel Therapies in FA$296,682
P01 · FY2012 · HL · contact PI
Cell Repository$296,679
P01 · FY2012 · HL · contact PI
Pathophysiology and Treatment of Fanconi's Anemia$2,111,574
P01 · FY2011 · HL · contact PI
Novel Sources of Transplantable Beta-cell Replacements$1,085,949
U01 · FY2011 · DK · contact PI
Treatment of Distal Tyrosine Pathway Disorders$327,642
R01 · FY2011 · DK · contact PI
Transplantation Assay for Liver Repopulating Cells$301,695
R01 · FY2011 · DK · contact PI
Administrative Core$301,653
P01 · FY2011 · HL · contact PI
preclinical Testing of Novel Therapies in FA$301,653
P01 · FY2011 · HL · contact PI
Cell Repository$301,653
P01 · FY2011 · HL · contact PI
Pathophysiology and Treatment of Fanconi's Anemia$2,116,459
P01 · FY2010 · HL · contact PI
Novel Sources of Transplantable Beta-cell Replacements$1,085,951
U01 · FY2010 · DK · contact PI
Modeling liver metabolism with patient-specific iPS derived hepatocytes$498,778
RC1 · FY2010 · DK
preclinical Testing of Novel Therapies in FA$446,802
P01 · FY2010 · HL · contact PI
Treatment of Distal Tyrosine Pathway Disorders$342,337
R01 · FY2010 · DK · contact PI
Transplantation Assay for Liver Repopulating Cells$304,742
R01 · FY2010 · DK · contact PI
Cell Repository$174,531
P01 · FY2010 · HL · contact PI
Administrative Core$90,064
P01 · FY2010 · HL · contact PI
Novel Reagents For Beta Cell Biology$772,250
U01 · FY2009 · DK · contact PI
Modeling liver metabolism with patient-specific iPS derived hepatocytes$500,000
RC1 · FY2009 · DK
Treatment of Distal Tyrosine Pathway Disorders$359,910
R01 · FY2009 · DK · contact PI
Transplantation Assay for Liver Repopulating Cells$307,821
R01 · FY2009 · DK · contact PI
Training in Developmental Biology$164,543
T32 · FY2009 · HD · contact PI
Transplantation Assay for Liver Repopulating Cells$100,500
R01 · FY2009 · DK · contact PI
PRE-CLINICAL THERAPY FOR FANCONI ANEMIA$505,218
P01 · FY2008 · HL · contact PI
Pathophysiology of Distal Tyrosine Pathway Disorders$308,500
R01 · FY2008 · DK · contact PI
Transplantation Assay for Liver Repopulating Cells$307,821
R01 · FY2008 · DK · contact PI
CORE C- FA CELL RESPOSITORY CORE$158,983
P01 · FY2008 · HL · contact PI
Novel Reagents For Beta Cell Biology$1
U01 · FY2008 · DK · contact PI
Novel Reagents For Beta Cell Biology$749,855
U01 · FY2007 · DK · contact PI
PRE-CLINICAL THERAPY FOR FANCONI ANEMIA$500,700
P01 · FY2007 · HL · contact PI
Transplantation Assay for Liver Repopulating Cells$324,787
R01 · FY2007 · DK · contact PI
Pathophysiology of Distal Tyrosine Pathway Disorders$314,796
R01 · FY2007 · DK · contact PI
Cell Therapy by In Vivo Fusion$270,849
R01 · FY2007 · DK · contact PI
CORE C- FA CELL RESPOSITORY CORE$157,539
P01 · FY2007 · HL · contact PI
Novel Reagents For Beta Cell Biology$1,555,823
U01 · FY2006 · DK · contact PI
Pathophysiology of Distal Tyrosine Pathway Disorders$324,198
R01 · FY2006 · DK · contact PI
PRE-CLINICAL THERAPY FOR FANCONI ANEMIA$312,186
P01 · FY2006 · HL · contact PI
Cell Therapy by In Vivo Fusion$279,332
R01 · FY2006 · DK · contact PI
CORE C- FA CELL RESPOSITORY CORE$98,221
P01 · FY2006 · HL · contact PI
Novel Reagents For Beta Cell Biology$753,978
U01 · FY2005 · DK
Pathophysiology of Distal Tyrosine Pathway Disorders$342,200
R01 · FY2005 · DK
PRE-CLINICAL THERAPY FOR FANCONI ANEMIA$303,093
P01 · FY2005 · HL
Cell Therapy by In Vivo Fusion$287,091
R01 · FY2005 · DK
Transplantation Assay for Liver Repopulating Cells$277,650
R01 · FY2005 · DK
CORE C- FA CELL RESPOSITORY CORE$95,360
P01 · FY2005 · HL
Novel Reagents For Beta Cell Biology$92,000
U01 · FY2005 · DK
PRE-CLINICAL THERAPY FOR FANCONI ANEMIA$295,969
P01 · FY2004 · HL
Cell Therapy by In Vivo Fusion$295,749
R01 · FY2004 · DK
PATHOPHYSIOLOGY AND TREATMENT OF DISORDERS IN THE DISTAL$290,942
R01 · FY2004 · DK
Transplantation Assay for Liver Repopulating Cells$278,664
R01 · FY2004 · DK
Isolation of Murine Pancreatic Liver Stem Cells$151,000
R21 · FY2004 · DK
CORE C- FA CELL RESPOSITORY CORE$102,583
P01 · FY2004 · HL
FASEB Conference: Mechanisms of Liver Growth and Disease$22,000
R13 · FY2004 · DK
PATHOPHYSIOLOGY AND TREATMENT OF DISORDERS IN THE DISTAL$282,468
R01 · FY2003 · DK
Transplantation Assay for Liver Repopulating Cells$279,650
R01 · FY2003 · DK
Isolation of Murine Pancreatic Liver Stem Cells$151,000
R21 · FY2003 · DK
Transplantation Assay for Liver Repopulating Cells$280,608
R01 · FY2002 · DK
PATHOPHYSIOLOGY AND TREATMENT OF DISORDERS IN THE DISTAL$274,242
R01 · FY2002 · DK
POSITIONAL CLONING OF FANC GENES &MODELS OF FANCONI ANEMIA$124,146
P01 · FY2002 · HL
CORE--FANCONI ANEMIA CELL REPOSITORY$124,146
P01 · FY2002 · HL
Transplantation Assay for Liver Repopulating Cells$288,431
R01 · FY2001 · DK
PATHOPHYSIOLOGY AND TREATMENT OF DISORDERS IN THE DISTAL$266,254
R01 · FY2001 · DK
POSITIONAL CLONING OF FANC GENES &MODELS OF FANCONI ANEMIA$124,146
P01 · FY2001 · HL
CORE--FANCONI ANEMIA CELL REPOSITORY$124,146
P01 · FY2001 · HL
CORE--FANCONI ANEMIA CELL REPOSITORY$314,458
P01 · FY2000 · HL
POSITIONAL CLONING OF FANC GENES &MODELS OF FANCONI ANEMIA$314,458
P01 · FY2000 · HL
TRANSPLANTATION ASSAY FOR LIVER REPOPULATING CELLS$236,030
R01 · FY2000 · DK
CREATION &ANALYSIS OF A MOUSE MODEL OF TYROSINEMIA$230,463
R01 · FY2000 · DK